back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-01-13 19:47 Tx date 2025-01-10 |
$NARA
Pangenomic Health Inc. |
Nygren, Robert Carl
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$165,750
+1,275,000 vol $0.13 each |
1,305,000 | |
| Filed 2025-01-13 19:46 Tx date 2025-01-10 |
$NARA
Pangenomic Health Inc. |
Nygren, Robert Carl
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$127,500
+1,275,000 vol $0.10 each |
1,318,000 | |
| Filed 2025-01-13 19:46 Tx date 2024-11-14 |
$NARA
Pangenomic Health Inc. |
Nygren, Robert Carl
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-120,000 vol |
30,000 | |
| Filed 2025-01-13 19:44 Tx date 2024-11-14 |
$NARA
Pangenomic Health Inc. |
Nygren, Robert Carl
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Holder: ETC3 Holdings Ltd. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-32,000 vol |
8,000 | |
| Filed 2025-01-13 19:44 Tx date 2024-11-14 |
$NARA
Pangenomic Health Inc. |
Nygren, Robert Carl
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-172,000 vol |
43,000 | |
| Filed 2024-03-25 18:18 Tx date 2024-03-21 |
$NARA
Pangenomic Health Inc. |
Nygren, Robert Carl
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-1,350,000 vol |
150,000 | |
| Filed 2024-03-25 18:16 Tx date 2024-03-21 |
$NARA
Pangenomic Health Inc. |
Nygren, Robert Carl
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Holder: ETC3 Holdings Ltd. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-360,000 vol |
40,000 | |
| Filed 2024-03-25 18:11 Tx date 2024-03-21 |
$NARA
Pangenomic Health Inc. |
Nygren, Robert Carl
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-1,935,000 vol |
215,000 | |
| Filed 2024-03-19 14:30 Tx date 2024-03-19 |
$NARA
Pangenomic Health Inc. |
Nygren, Robert Carl
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Holder: ETC3 Holdings Ltd. (Indirect Ownership)
|
Warrants
55 - Expiration of warrants
|
$-150,000
-500,000 vol $0.30 each |
0 | |
| Filed 2021-05-23 21:17 Tx date 2020-02-27 |
$NHS
NHS Industries Ltd. |
Nygren, Robert Carl
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+1,500,000 vol |
1,500,000 | |
| Filed 2021-05-23 21:15 Tx date 2019-12-30 |
$NHS
NHS Industries Ltd. |
Nygren, Robert Carl
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-09-04 10:23 Tx date 2020-09-04 |
$
HAVN Life Sciences Inc. |
Nygren, Robert Carl
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
4,500,000 | ||
| Filed 2020-09-04 10:22 Tx date 2020-09-04 |
$
HAVN Life Sciences Inc. |
Nygren, Robert Carl
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
4,315,280 |